According to a new report Europe Clot Management Devices Market, published by KBV Research, the Europe Clot Management Devices is expected to grow at a CAGR of 4.1% during the forecast period. The Percutaneous Thrombectomy Devices market dominated the Europe Clot Management Market by Product in 2015, and would continue to be a dominant market till 2022; thereby, achieving a market value of $153.3 million by 2022, growing at a CAGR of 2.6% during the forecast period.
The Neurovascular Embolectomy Devices market is expected to witness a CAGR of 6.5% during (2016 - 2022). The Germany market dominated the Europe Hospitals Clot Management Market by Country in 2015, and would continue to be a dominant market till 2022 growing at a CAGR of 2.7% during the forecast period. The France market is expected to witness a CAGR of 3% during (2016 - 2022). Additionally, The Spain market is expected to witness a CAGR of 3.7% during (2016 - 2022).
The report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the discussed region. The key influencing factors of the EuropeClot Management Devices have been discussed in the report along with the elaborated company profiles of Teleflex Inc., Edwards Lifesciences Corporation, Medtronic Plc, Boston Scientific Corporation, Lemaitre Vascular, Inc., Straub Medical AG, Cook Medical Inc. and Johnson & Johnson.
Full report : https://www.kbvresearch.com/europe-clot-management-devices-market/
Research Scope
Global Clot Management Devices Market
North America Clot Management Devices Market
Unique Offerings 
